NKE enters the post-earnings period in a state of reset — the June 30 Q4 print delivered a guidance cut to flat-to-low-single-digit FY2027 growth, and the Street spent the morning of July 1 repricing accordingly.
The analyst response was swift and largely unified in direction. The dominant move on July 1 was target cuts, not rating changes — most firms held their existing ratings while trimming numbers. UBS kept Neutral but dropped its target to $48 from $50. Citigroup did the same, cutting to $45 from $47. Piper Sandler and Stifel both landed at $45, down from $50. Guggenheim maintained Buy but made the largest absolute cut, pulling its target to $60 from $74. Bernstein kept Outperform but trimmed to $72 from $80. The consensus picture is a hold-heavy Street with a mean target of $51.86 — well above the $41.05 close — but that gap reflects the speed of the stock's decline more than bullish conviction. One firm, BNP Paribas, holds an Underperform with a $23 target, anchoring the bear end of the range. Baird and BTIG were the outliers, reiterating Outperform and Buy respectively without touching targets, but they are in the minority.
The bull case rests on new management executing the Sports Offense strategy, brand durability, and a path to stabilising North American market share. Bears point to valuation that remains above historical averages even after the decline — the P/E multiple has compressed roughly 5.9 points over the past month to 21.6x, and EV/EBITDA has fallen 3.1 points to 15.5x — but neither looks cheap given flat growth guidance. Factor scores add nuance: EPS momentum over both 30 and 90 days ranks in the 96th–99th percentile, reflecting the post-earnings estimate revision cycle, yet the EV/EBIT rank sits in the 33rd percentile and the short score rank at 37, neither of which suggests the market is pricing in a recovery.
Short positioning has stabilised rather than surged in the immediate post-earnings session. SI dipped fractionally on June 30 to 4.94% of the free float, ending a sharp 25% week-on-week build that had pushed shorts back to the June 1 peak level heading into the print. The borrow market remains entirely comfortable — availability is back above 1,000%, meaning ten shares are available for every one already lent out, and cost to borrow ticked up 32% on the week to 0.52%, still historically low. There is no squeeze pressure, and shorts face no practical constraint on maintaining or adding positions. Options positioning has settled into mild defensiveness: the put/call ratio at 0.76 is about 1.3 standard deviations above its 20-day average of 0.71, elevated but not at the extreme seen before the June 25 print.
The insider picture from April provides an interesting backdrop. CEO Elliott Hill bought just under $1 million of stock at $42.27 on April 13, and Lead Independent Director Tim Cook added $1.06 million at $42.43 on April 10 — both near the current price. That cluster of director-level buying near $42–$43 now sits roughly flat versus Tuesday's close, suggesting those buyers are neither vindicated nor badly underwater, though the guidance cut materially changed what they were buying into.
On the week, the closest correlated peers diverged sharply. UAA gained 10.6% — the strongest performance in the peer group — while CRI and CPRI fell roughly 3.7% and 3.0% respectively, echoing NKE's 3.1% weekly decline. The next earnings event is logged for October 1, making the next focal point less about near-term catalysts and more about whether the FY2027 guidance range — flat to low-single-digit growth — proves to be a floor or a ceiling as wholesale trends develop through the summer.
See the live data behind this article on ORTEX.
Open NKE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
